Tempus AI, Inc. stock surges 75% but flashes deep overbought signals
Tempus AI, Inc. stock surged to 72.69 on August 21 after a reported 75% rally. The market views its acquisition of Personalis‘ cancer monitoring tests as a strategic win. The stock now trades well above every major trend reference, with indicators reflecting significant extension.
Key takeaways
- TEM closed at 72.69 on August 21, above its daily upper Bollinger Band at 67.37 — a statistical outlier.
- The daily RSI14 reached 75.09 and the hourly RSI14 hit 82.38, both deep in overbought territory.
- The acquisition of Personalis‘ cancer monitoring tests is driving the rally, framed as a strategic AI precision medicine play.
- Insider sales were procedural — tied to Rule 10b5-1 plans or RSU tax withholding — not conviction-based selling.
- The 15-minute chart already shows momentum cooling, with a negative MACD histogram, signaling a possible near-term pause.
Daily Trend: Tempus AI, Inc. Stock Breaks Above Its Own Bollinger Band
On the daily chart, the bias is unambiguously bullish — but bullish in a way that eventually invites caution. Price closed at 72.69, far above the EMA20 (54.89), EMA50 (52.65) and EMA200 (56.70). That kind of separation between price and its moving averages is rare. It signals a trend that has moved very fast, very recently. The daily RSI14 at 75.09 confirms the strength of the move. However, it also sits deep in overbought territory — a zone where sharp reversals or pauses tend to originate.
… Continue reading the full article at the original source below.
